GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » EV-to-FCF

Pacific Edge (Pacific Edge) EV-to-FCF : -1.13 (As of Jun. 21, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Pacific Edge's Enterprise Value is $18.30 Mil. Pacific Edge's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-16.26 Mil. Therefore, Pacific Edge's EV-to-FCF for today is -1.13.

The historical rank and industry rank for Pacific Edge's EV-to-FCF or its related term are showing as below:

PFGTF' s EV-to-FCF Range Over the Past 10 Years
Min: -78.41   Med: -9.6   Max: 0.77
Current: -1.22

During the past 13 years, the highest EV-to-FCF of Pacific Edge was 0.77. The lowest was -78.41. And the median was -9.60.

PFGTF's EV-to-FCF is ranked worse than
100% of 90 companies
in the Medical Diagnostics & Research industry
Industry Median: 24.71 vs PFGTF: -1.22

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-21), Pacific Edge's stock price is $0.0437. Pacific Edge's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.021. Therefore, Pacific Edge's PE Ratio for today is At Loss.


Pacific Edge EV-to-FCF Historical Data

The historical data trend for Pacific Edge's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge EV-to-FCF Chart

Pacific Edge Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.58 -51.25 -33.16 -8.76 -0.83

Pacific Edge Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.16 - -8.76 - -0.83

Competitive Comparison of Pacific Edge's EV-to-FCF

For the Diagnostics & Research subindustry, Pacific Edge's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Edge's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Pacific Edge's EV-to-FCF falls into.



Pacific Edge EV-to-FCF Calculation

Pacific Edge's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=18.300/-16.259
=-1.13

Pacific Edge's current Enterprise Value is $18.30 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pacific Edge's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-16.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Edge  (OTCPK:PFGTF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pacific Edge's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0437/-0.021
=At Loss

Pacific Edge's share price for today is $0.0437.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pacific Edge's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.021.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Pacific Edge EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Pacific Edge's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Edge (Pacific Edge) Business Description

Traded in Other Exchanges
Address
87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016
Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.

Pacific Edge (Pacific Edge) Headlines

From GuruFocus

Half Year 2024 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2021 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Trading Halt Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024